Henoch Schonlein Purpura Haematological Disorders Coagulation defects, purpura and other haemorrhagic conditions
Conditions
Interventions
Intervention:
Prednisone 2 mg/kg for 7 days, 75% on days 8 and 9, 50% on days 10 and 11 and 25% on days 12, 13, 14, then stopped.
Control:
Comparison group was an identical appearing placebo.
Sponsors
Children's Hospital of Eastern Ontario Research Institute (CHEORI) (Canada)
Eligibility
Inclusion criteria
Inclusion criteria: Eligible participants were children between the ages of 2 and 15, presenting to the emergency room within 7 days of onset of Henoch Schonlein Purpura. Children were excluded if: 1. Another explanation for purpura was present 2. They had a known underlying systemic vasculitis 3. They had been treated with any form of corticosteroids in the preceding month 4. They had a known chronic illness affecting the renal, gastrointestinal or immune systems 5. They had an active infection 6. They were experiencing a life-threatening complication of Henoch Schonlein Purpura
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
Canada
Outcome results
None listed